Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05597709
What this trial is testing

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Who this might be right for
Type 2 Diabetes Mellitus in RemissionMetabolic Associated Fatty Liver Disease
Wuxi Hisky Medical Technology Co Ltd 2,900
Not applicableNot Yet RecruitingNCT07177963
What this trial is testing

CPET-based HIIT for MAFLD

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver Disease
Tang Yida 54
Post-approval studies (Phase 4)Active Not RecruitingNCT05782972
What this trial is testing

Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study

Who this might be right for
Metabolic Associated Fatty Liver Disease
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 50
Testing effectiveness (Phase 2)Looking for participantsNCT07512427
What this trial is testing

Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants

Who this might be right for
MASH
OPKO Health, Inc. 30
Not applicableLooking for participantsNCT07534241
What this trial is testing

Hepatoprotective Effects of Reishi Mushroom- (Ganoderma Lucidum) Among Metabolic Dysfunction-associated Fatty Liver Disease Patients

Who this might be right for
Lipid ProfileLiver Biomarkers
University of Lahore 102
Not applicableUnknownNCT06453239
What this trial is testing

Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD

Who this might be right for
Steatosis of Liver
Sohag University 80
Not applicableEnrolling By InvitationNCT06944353
What this trial is testing

Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseSteatosis of LiverMetabolic Dysfunction-Associated Steatotic Liver Disease
Northwestern University 4,704
Not applicableEnrolling By InvitationNCT06953830
What this trial is testing

Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
William Jennings Bryan Dorn VA Medical Center 100
Not applicableActive Not RecruitingNCT07172997
What this trial is testing

Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

Who this might be right for
MASLDT2DM (Type 2 Diabetes Mellitus)Non-alcoholic Fatty Liver Disease (NAFLD)+1 more
Royal College of Surgeons in Ireland - Medical University of Bahrain 163
Not applicableUnknownNCT05708560
What this trial is testing

Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study

Who this might be right for
Hepatitis B, Chronic
Erasmus Medical Center 800
Not applicableNot Yet RecruitingNCT07760909
What this trial is testing

Metabolic Flux Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated SteatohepatitisObesity+1 more
Vanderbilt University Medical Center 20
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableNot Yet RecruitingNCT07467512
What this trial is testing

Exercise for an Aging Liver (EXALIVER)

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASH - Metabolic Dysfunction-Associated SteatohepatitisLiver Fibrosis/NASH
Consorcio Centro de Investigación Biomédica en Red (CIBER) 40
Early research (Phase 1)WithdrawnNCT06138327
What this trial is testing

BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria

Who this might be right for
HyperoxaluriaNonalcoholic Fatty Liver DiseaseKidney Stone
BioMarin Pharmaceutical
Testing effectiveness (Phase 2)Active Not RecruitingNCT07466017
What this trial is testing

CS060380 Tablets in Patients With MASH and Obesity

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)Obesity
Cascade Pharmaceuticals, Inc 130
Not applicableActive Not RecruitingNCT06315361
What this trial is testing

DIAbetes and NAFLD

Who this might be right for
NAFLDDiabetesNASH+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Not applicableUnknownNCT05913986
What this trial is testing

Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver Disease
Saluz Investigación S. C. 50
Not applicableLooking for participantsNCT07192159
What this trial is testing

Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatic SteatosisLiver Disease Parenchymal
Seoul National University Hospital 62
Not applicableLooking for participantsNCT07463287
What this trial is testing

High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai East Hospital 100
Early research (Phase 1)Study completedNCT07801313
What this trial is testing

Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese Volunteers

Who this might be right for
Overweight , ObesityType 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd 55
Next Page